Johnson & Johnson shares were off more than 2% on Wednesday, a day after a U.S. ...
) shares were off more than 2% on Wednesday, a day after a U.S. jury said it must pay $8 billion in punitive damages to a plaintiff in a case involving its anti-psychotic drug Risperdal, a penalty the company and others are confident will not stand.
Gary Bradshaw, portfolio manager for the Hodges Blue Chip Equity Income fund, said he expects the total damages that J&J will pay to be “drastically reduced” on appeal. “Every pharmaceutical company needs to seriously consider if they want to litigate to verdict in the present environment, but with the settlement demands so incredibly high it’s not always clear what their alternative is,” said Barry Thompson, a partner at Baker McKenzie law firm who was not involved in the case.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Johnson & Johnson hit as jury awards 'excessive' $8 billion in damagesShares of Johnson & Johnson dipped 2% on Wednesday after a jury awarded $8 billi...
Weiterlesen »
Johnson & Johnson Ordered To Pay $8 Million In Male Breast Growth CaseJ&J said it would appeal the decision.
Weiterlesen »
J&J Hit With $8 Billion Jury Award Over Antipsychotic DrugA Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a man who said his use of J&J’s antipsychotic Risperdal caused enlarged breasts.
Weiterlesen »
$8 Billion Award in Risperdal LawsuitA lawsuit over the antipsychotic drug Risperdal has led to an $8 billion punitive damages award against Johnson & Johnson and one of its subsidiaries.
Weiterlesen »
Jury says J&J must pay $8 billion in case over male breast growth linked to RisperdalJohnson & Johnson must pay $8 billion in punitive damages to a man who previousl...
Weiterlesen »